Current management strategy of hepatocellular carcinoma
- PMID: 19598295
- PMCID: PMC2710775
- DOI: 10.3748/wjg.15.3210
Current management strategy of hepatocellular carcinoma
Abstract
Hepatocellular carcinoma (HCC) still remains a considerable challenge for surgeons. Surgery, including liver transplantation, is the most important therapeutic approach for patients with this disease. HCC is frequently diagnosed at advanced stages and has a poor prognosis with a high mortality rate even when surgical resection has been considered potentially curative. This brief report summarizes the current status of the management of this malignancy and includes a short description of new pharmacological approaches in HCC treatment.
Figures
Comment in
-
Hepatocellular carcinoma and evidence-based surgery.World J Gastroenterol. 2009 Nov 14;15(42):5371. doi: 10.3748/wjg.15.5371. World J Gastroenterol. 2009. PMID: 19908350 Free PMC article.
References
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–156. - PubMed
-
- Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology. 2002;122:1609–1619. - PubMed
-
- Liu JH, Chen PW, Asch SM, Busuttil RW, Ko CY. Surgery for hepatocellular carcinoma: does it improve survival? Ann Surg Oncol. 2004;11:298–303. - PubMed
-
- Fong TL, Kanel GC, Conrad A, Valinluck B, Charboneau F, Adkins RH. Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. Hepatology. 1994;19:554–557. - PubMed
-
- Ming L, Thorgeirsson SS, Gail MH, Lu P, Harris CC, Wang N, Shao Y, Wu Z, Liu G, Wang X, et al. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology. 2002;36:1214–1220. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
